SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001618835-21-000162
Filing Date
2021-07-30
Accepted
2021-07-30 16:37:47
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 evfm-sx3shelfregistrationj.htm S-3 347659
2 EX-4.4 exhibit44formofseniorinden.htm EX-4.4 432922
3 EX-4.5 exhibit45formofsubordinate.htm EX-4.5 433066
4 EX-5.1 evfm-shelfsx32021ex51opini.htm EX-5.1 40378
5 EX-23.1 a231consentofdeloittetouch.htm EX-23.1 2187
6 evofembiosciencesjpegfileab.jpg GRAPHIC 61097
7 image_1.jpg GRAPHIC 10797
8 mintzlogo.jpg GRAPHIC 12357
  Complete submission text file 0001618835-21-000162.txt   1368101
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258321 | Film No.: 211133130
SIC: 2834 Pharmaceutical Preparations